Once more, HPX’s role as a potential therapeutic was reinforced in a recent review on subarachnoid hemorrhage, which compared the pathophysiology in humans and rodents [105], and Hp is active in outcomes in patients after subarachnoid hemorrhage [106] or after ICH [107]. Here, HP is linked to subarachnoid hemorrhage.